[1]
CR, J. et al. 2022. THE ROLE OF HERBAL IMMUNOMODULATORS AS ADJUVANT THERAPY FOR ASYMPTOMATIC AND MILDLY SYMPTOMATIC COVID-19: AN EXPLORATORY CLINICAL STUDY. Asian Journal of Pharmaceutical and Clinical Research. 15, 3 (Mar. 2022), 78–86. DOI:https://doi.org/10.22159/ajpcr.2022.v15i3.44157.